Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FAQGL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $174,212
Award facts
- Contract value 100% obligated
- $174,211.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a competitive delivery order to AmerisourceBergen Drug Corp for $174,211.91 to supply Dupixent 300 mg/2 ml pens. The award, issued on September 25, 2025, with completion expected by September 26, 2025, represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion vehicle running through December 2026 that enables comprehensive pharmaceutical support across military and federal healthcare systems globally.
AmerisourceBergen Drug Corp maintains a robust portfolio of federal medical procurement contracts with the DLA, supplying a wide range of pharmaceutical products and medical supplies to support military healthcare operations and veteran services. The company's demonstrated capability to fulfill open competition awards across various therapeutic domains and product categories, combined with its status as a major pharmaceutical distributor and healthcare solutions provider, positions it as a critical vendor within the federal medical supply chain. The Dupixent delivery represents one of numerous competitively awarded transactions through which the company supplies specialty medications and brand-name drugs to support the Defense Health Agency and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DB25FAQGL?
SPE2DB25FAQGL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FAQGL worth?
The government has obligated $174,212 on SPE2DB25FAQGL.
Is contract SPE2DB25FAQGL an order under another contract?
Yes. SPE2DB25FAQGL is a delivery order under SPE2DB24D2105, an indefinite delivery contract.
Was contract SPE2DB25FAQGL competed?
The extent of competition for SPE2DB25FAQGL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award